# OnCo record nct06472245 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06472245/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06472245", "NCT06472245" ;
  schema:name "Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor"@en ;
  schema:alternateName "ARTEMIA"@en ;
  schema:description "A phase 3 trial testing OSE2101 in non-small-cell lung cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06472245/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06472245> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-12-03" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/ose2101/> ;
  onco:companies <https://onco.cc/companies/ose-immunotherapeutics/> .